$71.96
-0.77-1.06%
At close: Jun 11, 5:00 PM EST
$71.96
N/A
After Hours: 4:00 PM EST
National Health Investors Inc Stock Guidance
NHINYSE
National Health Investors (NHI) last issued guidance on May 4, 2026 for fiscal year 2026. The company guided earnings per share in the range of $4.74 - $4.79, compared to a consensus EPS estimate of $5.02.
Compared to prior guidance, National Health Investors lowered its EPS outlook from a previous range of $4.94 - $4.99.
National Health Investors has issued 16 guidance updates between August 8, 2022 and May 4, 2026. During this period, the company raised its outlook 9 times and lowered it 4 times, providing investors with insight into management's evolving expectations.
Latest Guidance Date
May 4, 2026
Guidance Period
Full Year 2026
EPS Guidance Range
$4.74 - $4.79
National Health Investors Guidance History
Review all historical guidance issued by National Health Investors, including EPS and revenue forecasts across quarterly and annual periods.
Loading calendar...
FAQ
What is the most recent guidance for National Health Investors (NHI)?
The most recent guidance for National Health Investors (NHI) was reported on May 4, 2026 for the fiscal year 2026. The company provided earnings per share guidance in the range of $4.74 to $4.79, compared to the estimated EPS of $5.02.
What EPS range did National Health Investors (NHI) guide for?
National Health Investors (NHI) guided EPS in the range of $4.74 to $4.79 for the fiscal year 2026. The consensus analyst EPS estimate is $5.02.
Did National Health Investors (NHI) raise or lower guidance?
National Health Investors (NHI) lowered its EPS guidance from a prior range of $4.94 - $4.99 to $4.74 - $4.79 for the fiscal year 2026.
When did National Health Investors (NHI) last issue guidance?
National Health Investors (NHI) last issued guidance on May 4, 2026 for the fiscal year 2026.
